AR131633A1 - Derivados novedosos de pirimidinil sulfonamida - Google Patents
Derivados novedosos de pirimidinil sulfonamidaInfo
- Publication number
- AR131633A1 AR131633A1 ARP240100112A ARP240100112A AR131633A1 AR 131633 A1 AR131633 A1 AR 131633A1 AR P240100112 A ARP240100112 A AR P240100112A AR P240100112 A ARP240100112 A AR P240100112A AR 131633 A1 AR131633 A1 AR 131633A1
- Authority
- AR
- Argentina
- Prior art keywords
- sulfonamide derivatives
- novel
- novel pyrimidinyl
- pyrimidinyl sulfonamide
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², R³, R⁴, R⁵ y R⁶ son como se describe en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP23152565 | 2023-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR131633A1 true AR131633A1 (es) | 2025-04-16 |
Family
ID=85019036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP240100112A AR131633A1 (es) | 2023-01-20 | 2024-01-18 | Derivados novedosos de pirimidinil sulfonamida |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250346580A1 (es) |
| EP (1) | EP4652158A1 (es) |
| JP (1) | JP2026502630A (es) |
| CN (1) | CN120530103A (es) |
| AR (1) | AR131633A1 (es) |
| TW (1) | TW202434245A (es) |
| WO (1) | WO2024153724A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI4298092T1 (sl) | 2021-02-26 | 2026-04-30 | F. Hoffmann-La Roche Ag | Novi derivati pirimidin-2-il sulfonamida |
| US20240299385A1 (en) | 2021-06-04 | 2024-09-12 | Rewind Therapeutics Nv | 3-pyrrolylsulfonamide compounds as gpr17 antagonists |
-
2024
- 2024-01-18 CN CN202480007906.8A patent/CN120530103A/zh active Pending
- 2024-01-18 EP EP24701565.4A patent/EP4652158A1/en active Pending
- 2024-01-18 WO PCT/EP2024/051094 patent/WO2024153724A1/en not_active Ceased
- 2024-01-18 AR ARP240100112A patent/AR131633A1/es unknown
- 2024-01-18 JP JP2025541979A patent/JP2026502630A/ja active Pending
- 2024-01-19 TW TW113102226A patent/TW202434245A/zh unknown
-
2025
- 2025-07-17 US US19/272,823 patent/US20250346580A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4652158A1 (en) | 2025-11-26 |
| TW202434245A (zh) | 2024-09-01 |
| WO2024153724A1 (en) | 2024-07-25 |
| CN120530103A (zh) | 2025-08-22 |
| JP2026502630A (ja) | 2026-01-23 |
| US20250346580A1 (en) | 2025-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR130984A1 (es) | Compuestos novedosos | |
| AR131278A1 (es) | Compuestos novedosos | |
| AR131006A1 (es) | Compuestos novedosos | |
| AR131282A1 (es) | Compuestos novedosos | |
| AR123424A1 (es) | Nuevos compuestos heterocíclicos | |
| CL2024004085A1 (es) | Compuestos macrocíclicos inhibidores de kras, uso para tratar cáncer. | |
| AR132377A1 (es) | Compuestos novedosos | |
| AR132340A1 (es) | Compuestos tricíclicos para el tratamiento de cáncer | |
| CL2023003312A1 (es) | Inhibidores de nlrp3 | |
| CO2023016212A2 (es) | Derivados de triazina y su uso en el tratamiento del cáncer | |
| ECSP20044709A (es) | Inhibidores de sarcómero cardíaco | |
| CL2023003154A1 (es) | Compuestos heterocíclicos | |
| CL2023002429A1 (es) | Derivados novedosos de pirimidin-2-il sulfonamida | |
| MX2021005714A (es) | Nuevos compuestos heterociclicos. | |
| AR116283A1 (es) | Inhibidores del sarcómero cardíaco | |
| CO2023013321A2 (es) | Compuestos de oxoisoindolina sustituidos con piridinilo | |
| CR20220638A (es) | Derivados de amidopirimidona | |
| CO2025002028A2 (es) | Derivados novedosos de indol sulfonamida 7 sustituidos | |
| AR132456A1 (es) | Compuestos novedosos | |
| CL2025000125A1 (es) | Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina. | |
| CO2025003256A2 (es) | Derivados novedosos deuterados de pirimidin-2-il sulfonamida | |
| CL2023002908A1 (es) | Compuestos heterocíclicos de arilo como bloqueadores del canal agitador de potasio kv1.3 | |
| CO2022012773A2 (es) | Moduladores de nampt | |
| AR133167A1 (es) | Macrociclos para el tratamiento de enfermedad autoinmunitaria | |
| AR133375A1 (es) | Compuestos novedosos |